Continuous ECG telemonitoring with implantable devices: the expected clinical benefits
|
|
|
- Amanda Park
- 5 years ago
- Views:
Transcription
1 Continuous ECG telemonitoring with implantable devices: the expected clinical benefits C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany
2 Declaration of Interest 1. Advisory Board Medtronic Inc. 2. Speaker s Bureau Biotronik Boston-Scientific Medtronic Inc. Sorin St. Jude Medical 3. Participation in Sponsored Trials Biotronik Boston-Scientific Medtronic Inc. Sorin St. Jude Medical
3 Remote ECG Monitoring: VT/VF 1. Remote ECG Monitoring for Early VT/VF Detection 2. Remote ECG Monitoring for Early AF Detection 3. Remote ECG Monitoring for Detection of HF Deterioration 4. Remote ECG Monitoring for Detection of Lead Failure
4 Remote ECG Monitoring: VT/VF Events in Dual-Chamber ICDs Lazarus, PACE 2007:30:S2-12
5 Remote ECG Monitoring: VT/VF Event % of patients Number of events* per patient affected Median, IQR Days from FU to first subsequent event Median, IQR Registry Other Registry Other Registry Other Technical events (1-1) 1 (1-1) 8 (3-13) 14 (5-16) Ventricular fibrillation (1-4) 2 (1-4) 15 (2-42) 17 (3-49) Ventricular tachycardia (1-10) 3 (1-11) 24 (7-48) 18 (5-42) Supraventricular tachycardia (5-13) 28 (6-132) 33 (13-52) 11 (21-62) 30 J shock ineffective (2-7) 2 (1-5) 9 (2-32) 17 (13-40) 1249 ICD patients, follow-up 9 ± 5 months Piorkowski, Autumn Meeting of the Geman Society of Cardiology 2005
6 Remote ECG Monitoring for Prevention of Inappropriate Shocks reprogram VT/SVT discriminators as soon as possible
7 Reduce Inappropriate Shocks Prognostic Implications of ICD Therapy: MADIT II Moss et al., Circulation 2004;110:760-5
8 Reduce Inappropriate Shocks Prognostic Implications of ICD Therapy: SCD-HeFT Poole et al., N Engl J Med 2007;28:601-7
9 Prognostic Implications of ICD Shocks: COMPANION Saxon, Circulation 2006;114:
10 Remote ECG Monitoring of VT/VF early notification of VT/VF episodes: allows early work-up (drug compliance, K+, ischemia, HF deterioration, ) allows early reprogramming to avoid further shocks may be relevant in electrical storm, incessant VTs may help prevent inappropriate shocks for SVT may help prevent inappropriate shocks for oversensing
11 Incessant Slow VT Detected by RM β blocker reinitiated β blocker stopped all VTs (> 200 within 1 week) terminated by ATP unnoticed by the patient Siaplaouras, Europace 2006;8:512 4
12 Electrical Storm: Incessant VT immediate professional advice via RM requires special organization ATP Shock
13 Ineffective Shock at Maximum Energy Ineffective Last Shock
14 Remote ECG Monitoring of VT/VF MV Glc Further Param. RR Kunze, Telemedizinführer 2003;78-81
15 Remote ECG Monitoring: VT/VF 1. Remote ECG Monitoring for Early VT/VF (SVT) Detection 2. Remote ECG Monitoring for Early AF Detection 3. Remote ECG Monitoring for Detection of HF Deterioration 4. Remote ECG Monitoring for Detection of Lead Failure
16 Asymptomatic AF > 48 hrs 38 % of pts with device-detected AF episodes > 48 h had no symptoms and were always SR at time of follow-up visit! Israel et al., JACC 2004;43:47-52
17 ASSERT Patient Eligibility - New dual-chamber pacemaker or ICD - Age 65 years - History of hypertension - Excluded if any history of AF or on vitamin K antagonist Pre-specified primary analysis - month 0 3: AT >6 min + >190 bpm - follow-up for ischemic stroke or systemic embolism Adjudication of all available AHRE
18 136 participating centres, 23 countries 2580 patients enrolled (2451 pacemaker patients, 129 ICD patients) Mean follow-up 2.8 years 36% of patients had at least one device-detected AT VKA use < 2% per year ASSERT
19 Cumulative Hazard Rates Time to 1 st AHRE ASSERT : Time to Adjudicated AHRE (>6 min >190 bpm) # at Risk Year month Visit Years of Follow-up
20 Cumulative Hazard Rates Stroke/Embolism in ASSERT # at Risk Year _ RR = % CI P = Device-Detected Atrial Tachyarrhythmia Detected month 0-3 No Asymptomatic Atrial Tachycardia Detected month T Years of Follow-up 0 at 3-month visit Healey et al., NEJM 2012
21 AFL Termination by Shock
22 Remote ECG Monitoring: VT/VF 1. Remote ECG Monitoring for Early VT/VF Detection 2. Remote ECG Monitoring for Early AF Detection 3. Remote ECG Monitoring for Detection of HF Deterioration 4. Remote ECG Monitoring for Detection of Lead Failure
23 Parameters for HF Monitoring Bui, JACC 2012;59:97 104
24 Parameters for HF Monitoring: Home-CARE 277 patients with a CRT-D system and daily remote monitoring Sack, Eur J Heart Fail 2011;13:
25 PARTNERS HF Whellan, J Am Coll Cardiol 2010;55:
26 Remote ECG Monitoring: VT/VF 1. Remote ECG Monitoring for Early VT/VF Detection 2. Remote ECG Monitoring for Early AF Detection 3. Remote ECG Monitoring for Detection of HF Deterioration 4. Remote ECG Monitoring for Detection of Lead Failure
27 ICD Lead Failure Up to 5% per year also in non-advisory ICD leads Kleemann, Circulation 2007;115:
28 Non-sustained Episodes of Non- Physiologically Fast Signals
29 Early Signs of Sprint Fidelis Failure Hauser, Heart Rhythm 2007;4:892-96
30 Electrical Abnormalities in Riata Ellenbogen, Heart Rhythm, Boston, May 2012
31 Prophylactic Replacement? 380 Medtronic Marquis devices, risk of malfunction 0.01% 1 out of 10,000 patients (0.038 of 380 patients) might develop an ICD problem 800fold general, 40fold death risk increase N = 45 (8.4%) Gould, JAMA 2006;295:
32 Automatic Alerts for Electrical Abnormalities Ellenbogen, Heart Rhythm, Boston, May 2012
33 ECG Monitoring and Automatic Alerts for Early Signs of Lead Failure non-physiologic short intervals nsvts representing oversensing ( noise ) VT with therapy representing oversensing ( noise ) sensing amplitude changes non-physiological signal morphology
34 Telemonitoring Spencker et al., Europace 2009;11:483-8
35 Interval between LIA Alert and Inappropriate Shock Delivery LIA: lead integrity alert, No CL: no CareLink, Non W-CL: nonwireless CareLink, W-CL: wireless CareLink Blanck, J Cardiovasc Electrophysiol 2011;22:
36 Detection of Riata Lead Failure by LIA RVtip-RVring Can-RVcoil Kneller, Europace 2012;22:
37 Sprint Fidelis Lead Failure Detection: ECOST 40 patients with Sprint fidelis leads 2 year remote monitoring remote monitoring with automatic alerts + in-hospital visit every 3 months alerts in 4 patients, lead failure confirmed in 3 patients 36 patients safe without any alert/intervention for 2 years Guédon-Moreau, Eur Heart J 2010;31:
38 Remote ECG Monitoring: Conclusion 1. Remote ECG Monitoring for Early VT/VF Detection 2. Remote ECG Monitoring for Early AF Detection 3. Remote ECG Monitoring for Detection of HF Deterioration 4. Remote ECG Monitoring for Detection of Lead Failure
Programming of Bradycardic Parameters. C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany
Programming of Bradycardic Parameters C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany Carsten.Israel@evkb.de Programming of ICD Brady Parameters Conflict of Interest Biotronik
Device Diagnostics and Stroke Prevention: State of the Art
Device Diagnostics and Stroke Prevention: State of the Art Ass. Prof. Dr. Carsten W. Israel Dept. of Cardiology Evangelical Hospital Bielefeld Germany C.W.Israel@em.uni-frankfurt.de Disclosure of Relationships
Subclinical AF: Implications of device based episodes
Subclinical AF: Implications of device based episodes Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Clinical Trials and Consulting: Medtronic, Boston Scientific
Inappropriate electrical shocks: Tackling the beast
ESC Paris 2011 Inappropriate electrical shocks: Tackling the beast Gerhard Hindricks University of Leipzig Heart Center Dept. of Electrophysiology ESC Paris 2011 Inappropriate electrical shocks: Tackling
Update on Device Innovation (S-ICD, Wearable, Leadless)
Update on Device Innovation (S-ICD, Wearable, Leadless) C. W. Israel Dept. of Medicine - Cardiology Evangelical Hospital Bielefeld J. W. Goethe University Frankfurt Carsten.Israel@em.uni-frankfurt.de Conflicts
Device Interrogation- Pacemakers, ICD and Loop Recorders. Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI
Device Interrogation- Pacemakers, ICD and Loop Recorders Dulce Obias-Manno, RN, MHSA, CCDS,CEPS, FHRS Device Clinic Coordinator, MHVI Disclosures Consultant: Medtronic Speaker s Bureau: St. Jude Medical
Shock Reduction Strategies Michael Geist E. Wolfson MC
Shock Reduction Strategies Michael Geist E. Wolfson MC Shock Therapy Thanks, I needed that! Why Do We Need To Reduce Shocks Long-term outcome after ICD and CRT implantation and influence of remote device
Remote monotoring of cardiac rhythm devices: present and future Pacemaker and ICD
Remote monotoring of cardiac rhythm devices: present and future Pacemaker and ICD Philippe Mabo University Hospital, Rennes, France ESC congress, Paris 30 August 2011 U642 Disclosures Biotronik: research
MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD
MADIT Studies: CRT in the Non-LBBB Patient and Other Findings Arthur J. Moss, MD University of Rochester Medical Cntr. Rochester, NY 13 th Annual New Frontiers in Heart Failure Rx NYC, NY January 26, 2013
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm
Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:
Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD
Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD Professor of Cardiology/Medicine Director of the Heart Research Follow Up Program, University of Rochester, Rochester,
Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients
ADVANCES IN CARDIAC ARRHYTHMIAS and GREAT INNOVATIONS IN CARDIOLOGY Turin October 13-15, 2016 Atrial fibrillation: why it's important to make opportunities diagnosis in single chamber ICD patients Dott.
Εκθορηίζεις απινιδωηή και θνηηόηηηα: μέθοδοι μείωζης ηων θεραπειών απινίδωζης
Εκθορηίζεις απινιδωηή και θνηηόηηηα: μέθοδοι μείωζης ηων θεραπειών απινίδωζης Εμμ. Μ. Κανοσπάκης Καρδιολογική Κλινική Πανεπιζηημίοσ Κρήηης Lessons from large trials Conditioning Rhythm and Electrical Therapy
Single- versus Dual-Coil ICD Leads: Does it Matter?
Single- versus Dual-Coil ICD Leads: Does it Matter? C. W. Israel, M.D. Dept. of Cardiology Evangelical Hospital Bielefeld Germany Carsten.Israel@evkb.de Conflict of Interest Biotronik Boston-Scientific
Preventing Sudden Death Current & Future Role of ICD Therapy
Preventing Sudden Death Current & Future Role of ICD Therapy Derek V Exner, MD, MPH, FRCPC, FACC, FAHA, FHRS Professor, Libin Cardiovascular Institute of Alberta Canada Research Chair, Cardiovascular Clinical
Tachycardia Devices Indications and Basic Trouble Shooting
Tachycardia Devices Indications and Basic Trouble Shooting Peter A. Brady, MD., FRCP Cardiology Review Course London, March 6 th, 2014 2011 MFMER 3134946-1 Tachycardia Devices ICD Indications Primary and
Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy
Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: Consulting and Clinical Trials Medtronic
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD) D. D. MANOLATOS, MD, PhD, FESC Electrophysiology and Device Lab General Hospital Evangelismos, Athens The Problem: 300,000 people die each year
The Role of ICD Therapy in Cardiac Resynchronization
The Role of ICD Therapy in Cardiac Resynchronization The Korean Society of Circulation 15 April 2005 Angel R. León, MD Carlyle Fraser Heart Center Division of Cardiology Emory University School of Medicine
Diagnostic capabilities of the implantable therapeutic systems
Cardiac pacing 2012 and beyound Monday August 27, 2012 Diagnostic capabilities of the implantable therapeutic systems Pekka Raatikainen Heart Center Co. Tampere University Hospital and University of Tampere
HF and CRT: CRT-P versus CRT-D
HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA
Atrial fibrillation and stroke. Isabelle C Van Gelder University Medical Center Groningen The Netherlands
Atrial fibrillation and stroke Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January 2018 Content Stroke what is the problem for patients with AF?
ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES
ECG monitoring after ischemic stroke of TIA of unknown source with an insertable monitor? YES Isabelle C Van Gelder University Medical Center Groningen The Netherlands ESC stroke council Prague January
La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente. Maurizio Gasparini
La gestione di un paziente con ICD: come evitare gli shock inappropriati e prolungare la sopravvivenza del paziente Maurizio Gasparini Responsabile UO Elettrofisiologia ed Elettrostimolazione Humanitas
ICD Discrimination Algorithms
ICD Discrimination Algorithms How Do They Work? Ji-Hae Yun, RN Certified Cardiac Device Specialist by IBHRE Asan Medical Center, Seoul Korea EGM of A.Fib with fast ventricular response Case 1 A EGM V EGM
ICD THERAPIES: are they harmful or just high risk markers?
ICD THERAPIES: are they harmful or just high risk markers? Konstantinos P. Letsas, MD, PhD, FESC LAB OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL ATHENS ICD therapies are common In a meta-analysis
Defibrillation threshold testing should no longer be performed: contra
Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose
Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use?
Implantable Cardiac Monitors for Atrial Fibrillation (AF) Detection: Ready for Routine Use? Helmut Pürerfellner, MD, Assoc. Prof. Saint Elisabeth s Sisters Hospital Academic Teaching Center Linz/Austria
SUBCUTANEOUS ICD ITS JOURNEY FROM PROOF OF CONCEPT TO CURRENT EVOLUTION
SUBCUTANEOUS ICD ITS JOURNEY FROM PROOF OF CONCEPT TO CURRENT EVOLUTION Giovanni Luca Botto MD, FEHRA, FESC Electrophysiology Unit ASST Lariana, Como, Italy Presenter Disclosure Information Research support:
Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.
Saving Lives and Preventing Heart Failure: The MADIT Family of Trials Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY Update in Electrocardiography
Risk Stratification of Sudden Cardiac Death
Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of
Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks
Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks Alireza Ghorbani Sharif, MD Interventional Electrophysiologist Tehran Arrhythmia Clinic January 2016 Recurrent ICD shocks are associated
Reducing Inappropriate and Appropriate Therapy in Primary Preven7on Pa7ents
Reducing Inappropriate and Appropriate Therapy in Primary Preven7on Pa7ents Jonathan S. Steinberg, MD Director, Arrhythmia Ins7tute Valley Health System Professor of Medicine (adj) University of Rochester
How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France
How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information Christophe Leclercq, MD,
New scientific documents from EHRA Management of patients with defibrillator shocks
New scientific documents from EHRA Management of patients with defibrillator shocks Frieder Braunschweig MD PhD FESC Karolinska University Hospital Stockholm, Sweden Evolution of ICD therapy Worldwide
INNOVATIONS IN DEVICE THERAPY:
INNOVATIONS IN DEVICE THERAPY: Subcutaneous ICDs, Leadless Pacemakers, CRT Indications David J Wilber MD Loyola University Medical Center Disclosures: ACC Foundation: Consultant; Biosense / Webster: Consultant,
Troubleshooting ICD. NASPE Training Lancashire & South Cumbria Cardiac Network
Troubleshooting ICD NASPE Training Lancashire & South Cumbria Cardiac Network Bradycardia Pacing by ICD Isolated ICD discharge Multiple discharges Appropriate Inappropriate No ICD Therapy or delay in ICD
Tachyarrhythmia Suspicion and Detection
Tech Corner Tachyarrhythmia Suspicion and Detection NOTE: PLEASE NOTE THAT THE FOLLOWING INFORMATION IS A GENERAL DESCRIPTION OF THE FUNCTION. DETAILS AND PARTICULAR CASES ARE NOT DESCRIBED IN THE ARTICLE.
Device based CRT optimization: is there a future? Lessons learned from published trials
Device based CRT optimization: is there a future? Lessons learned from published trials C. Leclercq Department of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information
Subcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention
Subcutaneous ICD Emerging Role of Sudden Cardiac Death Prevention Dr Ngai-Yin Chan, MBBS, FRCP(Lond), FRCP(Edin), FRCP(Glasg), FACC, FHRS, Consultant Physician, Department of Medicine & Geriatrics, Princess
Introduction. CLINICAL RESEARCH Clinical Trial Design. Mohammad Saeed 1 *, Mehdi Razavi 1, Curtis G. Neason 2, and Simona Petrutiu 2. Aims.
Europace (2011) 13, 1648 1652 doi:10.1093/europace/eur195 CLINICAL RESEARCH Clinical Trial Design Rationale and design for programming implantable cardioverter defibrillators in patients with primary prevention
PARAD/PARAD+ : P and R Based Arrhythmia Detection
Tech Corner PARAD/PARAD+ : P and R Based Arrhythmia Detection NOTE: PLEASE NOTE THAT THE FOLLOWING INFORMATION IS A GENERAL DESCRIPTION OF THE FUNCTION. DETAILS AND PARTICULAR CASES ARE NOT DESCRIBED IN
Device Implantation: Long-Term Commitments. Fayez Bokhari, MD, FRCPC Director of Cardiology Military Hospital, Jeddah
Device Implantation: Long-Term Commitments Fayez Bokhari, MD, FRCPC Director of Cardiology Military Hospital, Jeddah Who should Implant ICD? 1. Electrophysiologist 2. Surgeons 3. General Cardiologist with
The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study
The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study Taya V. Glotzer, MD; Emile G. Daoud, MD; D. George Wyse, MD, PhD; Daniel
Device Update Implantable Cardioverter Defibrillator (ICD) 박상원
2012 년춘계학술대회 Device Update Implantable Cardioverter Defibrillator (ICD) 박상원 Arrhythmia Center, KUMC www.korea-heartrhythm.com Korea University Medical Center Seoul, Korea The Development of ICD by a team
HRS Abstract from the ALTITUDE Clinical Science Program as presented at Heart Rhythm Society Conference, May 2011; San Francisco, CA USA
HRS Abstract from the ALTITUDE Clinical Science Program as presented at Heart Rhythm Society Conference, May 2011; San Francisco, CA USA Disclaimer The content in this presentation was published in the
ICD Therapy. Disclaimers
ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.
SVT Discriminators. Definition of SVT Discrimination. Identify which patient populations might benefit from these features
Definition of SVT Discrimination Identify which patient populations might benefit from these features Understand the 4 types of SVT discriminators used by St Jude Medical Be aware of programmable parameters
How to prevent unecessary right ventricular pacing
How to prevent unecessary right ventricular pacing Jens Cosedis Nielsen, MD, PhD, DMSci Dept of Cardiology, Aarhus University Hospital, Skejby, Denmark June 27, 2011, Europace Madrid Conflicts of interest
Make the Connection A clinical compendium on the relationship between AF, stroke, and early intervention
Make the Connection A clinical compendium on the relationship between AF, stroke, and early intervention Data that date back to the 1970 s have illustrated the strong relationship between atrial fibrillation
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
ESC Paris Remote monitoring of cardiac rhythm devices: present and future HEART FAILURE
ESC Paris 11-08-30 Remote monitoring of cardiac rhythm devices: present and future HEART FAILURE Frieder Braunschweig MD PhD FESC Associate Professor of Cardiology Karolinska University Hospital Stockholm,
John H. Ip, M.D FACC Associate Professor of Medicine Michigan State University Medical Director, EP Service
ICD Trouble shooting: Case study John H. Ip, M.D FACC Associate Professor of Medicine Michigan State University Medical Director, EP Service Bullet proof evidence: ICD does prevent sudden death Disclosures
Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine
Devices and Other Non- Pharmacologic Therapy in CHF Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Disclosure None University of Miami vs. OSU Renegade Miami football
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure
Implantable Cardioverter Defibrillator Therapy in MADIT II Patients with Signs and Symptoms of Heart Failure Wojciech Zareba Postinfarction patients with left ventricular dysfunction are at increased risk
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
Top 5 Things to Know about Pacemakers and ICD s. Jeffrey S. Osborn, M.D., C.C.D.S. March 4, 2017.
Top 5 Things to Know about Pacemakers and ICD s Jeffrey S. Osborn, M.D., C.C.D.S. March 4, 2017. Top 5 Things 1. Remote Monitoring leads to better care and outcomes. 2. MRI s CAN be done on device patients.
Performance of Atrial Fibrillation Detection in a New Single-Chamber ICD
DEVICES Performance of Atrial Fibrillation Detection in a New Single-Chamber ICD ABHISHEK DESHMUKH, M.D.,* MARK L. BROWN, PH.D., ELISE HIGGINS, B.S., BRIAN SCHOUSEK, B.S., ATHULA ABEYRATNE, PH.D., GIOVANNI
ICD Shocks: How to Avoid? Josef Kautzner Department of Cardiology, Institute for Clinical and Experimental Medicine Prague, Czech Republic
ICD Shocks: How to Avoid? Josef Kautzner Department of Cardiology, Institute for Clinical and Experimental Medicine Prague, Czech Republic joka@medicon.cz www.ikem.cz My Disclosures Advisory Board member
Journal of Arrhythmia
Journal of Arrhythmia 28 (2012) 91 95 Contents lists available at SciVerse ScienceDirect Journal of Arrhythmia journal homepage: www.elsevier.com/locate/joa Review Unresolved matters related to implantable
SUBCLINICAL ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE DEVICEs ORAL ANTICOAGULANT THERAPY: TO GIVE OR NOT TO GIVE, THIS IS THE PROBLEM!!
SUBCLINICAL ATRIAL FIBRILLATION IN PATIENTS WITH IMPLANTABLE DEVICEs ORAL ANTICOAGULANT THERAPY: TO GIVE OR NOT TO GIVE, THIS IS THE PROBLEM!! Atrial tachycardia «ATRIAL HIGH RATES EPISODES» (AHREs) Episodes
State of the art of ICD programming: Lessons learned and future directions
Neth Heart J (2014) 22:415 420 DOI 10.1007/s12471-014-0582-4 REVIEW ARTICLE State of the art of ICD programming: Lessons learned and future directions M. H. Mastenbroek & S. S. Pedersen & H. Versteeg &
Current clinical evidence for remote patient management
Europace (2013) 15, i6 i10 doi:10.1093/europace/eut119 Current clinical evidence for remote patient management Laurence Guédon-Moreau 1 *, Philippe Mabo 2,3, and Salem Kacet 1 1 Hôpital Cardiologique,
What You Should Know About Subcutaneous and Transvenous ICD
What You Should Know About Subcutaneous and Transvenous ICD N. A. Mark Estes III MD Professor of Medicine Tufts University School of Medicine Director, New England Cardiac Arrhythmia Center Tufts Medical
ICD Diagnostics: Making the most of it
ICD Basics and Beyond ICD Diagnostics: Making the most of it Dulce Obias-Manno RN, BSN, MHSA, FHRS, CCDS, CEPS Cardiac Arrhythmia Center, Device Clinic Washington Hospital Center, Washington DC Objectives
CARDIAC DEVICE MR-CONDITIONAL PRODUCT SUMMARY CHART
CARDIAC DEVICE MR-CONDITIONAL PRODUCT SUMMARY CHART December 2015 This chart encompasses all Medtronic cardiac devices FDA-Approved as MR Conditional and included in the MRI SureScan portfolio. If a device
Primary Therapy for High Risk LQT Patients Should Be an ICD
Primary Therapy for High Risk LQT Patients Should Be an ICD Raul Weiss MD, FAHA, FACC, FHRS, CCDS Director, Electrophysiology Fellowship Program Associate Professor of Medicine The Ohio State University
Device detected VT: How much VT is significant and is VT ablation the answer?
Device detected VT: How much VT is significant and is VT ablation the answer? Dr Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust What is VT (in this context)? What is VT?
Fibrillazione atriale : causa diretta marker di rischio di eventi cerebrovascolari non solo embolici?
Fibrillazione atriale : causa diretta marker di rischio di eventi cerebrovascolari non solo embolici? Fabrizio Ammirati Dipartimento Medicina UOC Cardiologia Ospedale GB Grassi ASL Roma 3 Sept 2013 Patients
Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA
Catheter Ablation of Recurrent Ventricular Tachycardia Should Be Done Before Antiarrhythmic Therapy with Amiodarone is Tried CONTRA Erik Wissner, MD, F.A.C.C. Director - Magnetic Navigation Laboratory
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia
The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh
Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention
Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University
Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University Disclosures Research Grants and speaking fees St. Jude
Should ICD Replacement Be Performed in Octogenarians and/or Severe Comorbidities?
Should ICD Replacement Be Performed in Octogenarians and/or Severe Comorbidities? JC Daubert Rennes, France Disclosure 2008-2011 Medical devices Speaker Consultant Trial committees EBR + + Impulse Dynamics
Treatment of VT of Purkinje fiber origin: ablation targets and outcome
Treatment of VT of Purkinje fiber origin: ablation targets and outcome Ch. Piorkowski University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany Presenter Disclosure Information Gerhard
Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In?
Where Does the Wearable Cardioverter Defibrillator (WCD) Fit In? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor of Medicine Director,
Follow-up of CRT patients ESC Munich Clinical and biological follow-up of CRT patients
Follow-up of CRT patients ESC Munich 12-08-26 Clinical and biological follow-up of CRT patients Frieder Braunschweig MD PhD FESC Associate Professor of Cardiology Karolinska University Hospital Stockholm,
Treatment of Atrial Fibrillation in Heart Failure
Stockholm, September 1st 2010 Treatment of Atrial Fibrillation in Heart Failure Rhythm control: Which drugs? Stefan H. Hohnloser J.W. Goethe University Frankfurt, Germany Presenter disclosure information:
Diagnostic Value of the ICD Atrial Lead in Accurate Discrimination of Supraventricular from Ventricular Arrhythmias The ALTITUDE EGM Study
Diagnostic Value of the ICD Atrial Lead in Accurate Discrimination of Supraventricular from Ventricular Arrhythmias The ALTITUDE EGM Study Brian D. Powell, MD, Yong-Mei Cha, MD, Paul W. Jones, MS, Milan
How Wireless Remote Monitoring Improves Clinical Benefits;
How Wireless Remote Monitoring Improves Clinical Benefits; A CLINICAL CASE STUDY Suneet Mittal, M.D., The Arrhythmia Institute at Valley Hospital, Ridgewood, NJ; New York, New York; E. Martin Kloosterman,
Selecting the Best ICD for your Patient-SICD v. TV. Martin C. Burke DO, FACOI CorVita Science Foundation & Academic Medical Center, Amsterdam
Selecting the Best ICD for your Patient-SICD v. TV Martin C. Burke DO, FACOI CorVita Science Foundation & Academic Medical Center, Amsterdam COI DISCLOSURES I have received lecture and proctoring honoraria
Spontaneous Atrial Fibrillation and Noacs and Reversal agents
Spontaneous Atrial Fibrillation and Noacs and Reversal agents Laurent Lewkowiez, MD Regional Service Chief, Hospital Cardiology CPMG Cardiac Electrophysiology Educational Goals relationship between atrial
Polypharmacy - arrhythmic risks in patients with heart failure
Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012
Defining Sub-Clinical Atrial Fibrillation and its management
Defining Sub-Clinical Atrial Fibrillation and its management Jeff Healey MD, MSc, FRCP, FHRS PHRI Chair in Cardiology Research Population Health Research Institute McMaster University, Canada Sub-Clinical
ICD leads survival and troubles in the last 10 years
XVI Symposium on Progress in Clinical Pacing, Rome, Italy - Dec 2 to 7, 2014 ICD leads survival and troubles in the last 10 years Antonio Raviele, MD, FESC, FHRS President ALFA Alliance to Fight Atrial
Diagnosing atrial fibrillation using implantable devices
Diagnosing atrial fibrillation using implantable devices Axel Brandes, MD, FESC Associate Professor of Electrophysiology and Cardiac Arrhythmias Dept. of Cardiology, Odense University Hospital, DK HRC
Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life
Chapter 3 Primary prevention ICD recipients: the need for defibrillator back-up after an event-free first battery service-life Guido H. van Welsenes, MS, Johannes B. van Rees, MD, Joep Thijssen, MD, Serge
OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices
OHTAC Recommendation: Internet- Based Device-Assisted Remote Monitoring of Cardiovascular Implantable Electronic Devices Ontario Health Technology Advisory Committee January 2012 Issue Background The Ontario
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease
The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology
Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverterdefibrillator
Europace (2015) 17, 1068 1075 doi:10.1093/europace/euv007 CLINICAL RESEARCH Sudden death and ICDs Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias
EUROPACE 2011 Johan Vijgen, MD, FESC Jessa Hospital Hasselt, Belgium
ICD and Driving: What is Safe? EUROPACE 2011 Johan Vijgen, MD, FESC Jessa Hospital Hasselt, Belgium Background Increasing number of ICD implants, more primary indications, patients are younger and more
Reducing unnecessary and inappropriate therapy in secondary prevention patients
Reducing unnecessary and inappropriate therapy in secondary prevention patients Maurizio Gasparini, MD Chief of EP and Pacing Unit Humanitas Research Hospital, Rozzano-Milano Italy Goals of Optimal ICD
Multisite Left Ventricular Pacing for Cardiac Resynchronization
Multisite Left Ventricular Pacing for Cardiac Resynchronization C. W. Israel, M.D. Ass. Prof. Dept. of Medicine Cardiology Evangelical Hospital Bielefeld Germany J. W. Goethe University Frankfurt C.W.Israel@em.uni-frankfurt.de
Automatic Identification of Implantable Cardioverter-Defibrillator Lead Problems Using Intracardiac Electrograms
Automatic Identification of Implantable Cardioverter-Defibrillator Lead Problems Using Intracardiac Electrograms BD Gunderson, AS Patel, CA Bounds Medtronic, Inc., Minneapolis, USA Abstract Implantable
Summary, conclusions and future perspectives
Summary, conclusions and future perspectives Summary The general introduction (Chapter 1) of this thesis describes aspects of sudden cardiac death (SCD), ventricular arrhythmias, substrates for ventricular
NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS
NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS OBJECTIVES Discuss history of ICDs Review the indications for ICD and CRT therapy Describe basic lead and device technology Discuss different therapies
Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες
Εμφύτευση απινιδωτών για πρωτογενή πρόληψη σε ασθενείς που δεν περιλαμβάνονται στις κλινικές μελέτες Δημήτριος M. Κωνσταντίνου Ειδικός Καρδιολόγος, MD, MSc, PhD, CCDS Πανεπιστημιακός Υπότροφος Dr. Konstantinou
Integration of diagnostic device information to improve patient management
Integration of diagnostic device information to improve patient management Haran Burri Associate Professor Cardiology Service University Hospital of Geneva Disclosures Biotronik: fellowship support, speaker
Novel Approaches to VT Management Glenn M Polin MD
Novel Approaches to VT Management Glenn M Polin MD Medical Director, Electrophysiology Laboratory John Ochsner Heart and Vascular Institute New Orleans, LA Disclosures Pfizer Speaker Bureau Bristol Myers
THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA
THE ROLE OF ICD THERAPY FOR PRIMARY PREVENTION Leonard Ganz, M.D. Pittsburgh, PA Speakers Bureau: Zoll / Lifecore, Sanofi Aventis, Cardionet Consultant: Boston Scientific, St. Jude Medical, Biotronik,